| 发明名称 |
Use of an adrenal hormone-modifying agent |
| 摘要 |
The present invention relates to a method of treating a disease or disorder characterised by increased stress hormone levels and/or decreased androgen hormone levels in a subject, comprising administering to the subject a therapeutically effective amount of a compound represented by formula (I): wherein n is 1 or 3; R is hydrogen or --C(O)N(R |
| 申请公布号 |
AU2011205290(C1) |
申请公布日期 |
2014.11.06 |
| 申请号 |
AU20110205290 |
申请日期 |
2011.01.13 |
| 申请人 |
NOVARTIS AG |
发明人 |
HU, QI-YING;KSANDER, GARY;MEREDITH, ERIK;MONOVICH, LAUREN G.;PAPILLON, JULIEN;SCHUMACHER, CHRISTOPH |
| 分类号 |
A61P5/00;A61K31/4188;A61K31/55 |
主分类号 |
A61P5/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
